Drug Information

Drug General Information
Drug ID
D0U2QP
Former ID
DNC010657
Drug Name
4-(3-hexylureido)-N-phenylbenzenesulfonamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530395]
Structure
Download
2D MOL

3D MOL
Formula
C19H25N3O3S
Canonical SMILES
CCCCCCNC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2
InChI
1S/C19H25N3O3S/c1-2-3-4-8-15-20-19(23)21-16-11-13-18(14-12-16)26(24,25)22-17-9-6-5-7-10-17/h5-7,9-14,22H,2-4,8,15H2,1H3,(H2,20,21,23)
InChIKey
ADKICSRVDIFTQJ-UHFFFAOYSA-N
PubChem Compound ID
46882764
Target and Pathway
Target(s) Growth hormone secretagogue receptor type 1 Target Info Inhibitor [530395]
KEGG Pathway cAMP signaling pathway
Neuroactive ligand-receptor interaction
NetPath Pathway Leptin Signaling Pathway
Reactome Peptide ligand-binding receptors
G alpha (q) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 530395Bioorg Med Chem Lett. 2009 Nov 1;19(21):6237-40. Epub 2009 Aug 26.Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists.
Ref 530395Bioorg Med Chem Lett. 2009 Nov 1;19(21):6237-40. Epub 2009 Aug 26.Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.